Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Martin J. Gepsman

At a glance: Martin J. Gepsman is Director at CME Group (CME). Their latest SEC Form 4, filed Oct 22, 2026, reported a sale of $121K. On file: 0 purchase lines ($0) and 2 sale lines ($213K).

Disclosed holdings: about $7.9M of CME stock: 25,244 shares reported on their latest Form 4 (filed Oct 22, 2026), valued at the Nov 20, 2026 close of $311.15. This counts only CME shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Cme Group Inc. (CME)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $213K

Martin J. Gepsman's InsiderPrint

2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Martin J. Gepsman: 2 trades, 2026 to 20262026: 0 buys, 2 sales
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Oct 22SEC CMECme Group Inc. Sell 40025,244 held (−2%) $302.50 $121K +2.9%
Feb 20SEC CMECme Group Inc. Sell 30024,999 held (−1%) $305.90 $92K +1.7%

Follow Martin J. Gepsman

Get one email when Martin J. Gepsman files a new purchase or sale. Free.

At most one email a day about Martin J. Gepsman, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.